scholarly article | Q13442814 |
P2093 | author name string | Martin Krönke | |
Katussevani Bernardo | |||
Marcus Klein | |||
Arne Kötz | |||
P2860 | cites work | The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation | Q37876392 |
Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease | Q37877922 | ||
Single channel analysis of recombinant major outer membrane protein porins from Chlamydia psittaci and Chlamydia pneumoniae | Q37878900 | ||
Antigenic and molecular analyses of different Chlamydia pneumoniae strains. | Q37883393 | ||
Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer | Q37883417 | ||
Immunoreactivity of the 60 kDa cysteine-rich proteins of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae expressed in Escherichia coli | Q37888611 | ||
Outer membrane complex proteins of Chlamydia pneumoniae | Q37890342 | ||
A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity | Q37890729 | ||
Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections | Q37892198 | ||
Sequence analysis of the major outer membrane protein gene of Chlamydia pneumoniae | Q37894914 | ||
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
Immunologic Relationship Between Genital Tric, Lymphogranuloma Venereum, and Related Organisms in a New Microtiter Indirect Immunofluorescence Test | Q37914183 | ||
Labsystems enzyme immunoassay for Chlamydia pneumoniae also detects Chlamydia psittaci infections | Q42727780 | ||
Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. | Q22065998 | ||
Comparative genomes of Chlamydia pneumoniae and C. trachomatis | Q22122313 | ||
Species-, serogroup-, and serovar-specific epitopes are juxtaposed in variable sequence region 4 of the major outer membrane proteins of some Chlamydia trachomatis serovars | Q28284011 | ||
Identification of Staphylococcus aureus exotoxins by combined sodium dodecyl sulfate gel electrophoresis and matrix-assisted laser desorption/ ionization-time of flight mass spectrometry | Q30835993 | ||
Analysis of the humoral immune response to Chlamydia outer membrane protein 2. | Q33654804 | ||
Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies | Q33905858 | ||
Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease | Q33941659 | ||
Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation. | Q33997961 | ||
Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae | Q33998580 | ||
Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants | Q34007275 | ||
Recombination in the ompA gene but not the omcB gene of Chlamydia contributes to serovar-specific differences in tissue tropism, immune surveillance, and persistence of the organism | Q34011963 | ||
Isolation of Chlamydia pneumoniae clonal variants by a focus-forming assay | Q34132478 | ||
Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals | Q34203352 | ||
Chlamydia pneumoniae infection of the central nervous system | Q34260373 | ||
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). | Q34312881 | ||
Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't | Q34572654 | ||
Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. | Q35093651 | ||
Chlamydia pneumoniae (TWAR). | Q35367697 | ||
Characterization of the murine antibody response to peptides representing the variable domains of the major outer membrane protein of Chlamydia pneumoniae | Q35513577 | ||
Improvement of growth of Chlamydia pneumoniae on HEp-2 cells by pretreatment with polyethylene glycol in combination with additional centrifugation and extension of culture time. | Q36545356 | ||
Prediction of the membrane-spanning beta-strands of the major outer membrane protein of Chlamydia | Q36639464 | ||
Structural and antigenic analysis of Chlamydia pneumoniae | Q36975448 | ||
The low-molecular-mass, cysteine-rich outer membrane protein of Chlamydia trachomatis possesses both biovar- and species-specific epitopes. | Q37007534 | ||
Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans | Q37072769 | ||
Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene. | Q37095262 | ||
Failure to detect Chlamydia pneumoniae in senile calcific aortic stenosis or calcified congenital bicuspid aortic valve by immunofluorescence, polymerase chain reaction and electron microscopy | Q37871128 | ||
Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target | Q37875182 | ||
Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. | Q37876203 | ||
Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection | Q37876328 | ||
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results | Q37876389 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
membrane protein | Q423042 | ||
Chlamydia pneumoniae | Q62869737 | ||
P304 | page(s) | 1957-1962 | |
P577 | publication date | 2003-05-01 | |
P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
P1476 | title | Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein | |
Detection of Chlamydia pneumoniae -Specific Antibodies Binding to the VD2 and VD3 Regions of the Major Outer Membrane Protein | |||
P478 | volume | 41 |
Q30155102 | A novel transport mechanism for MOMP in Chlamydophila pneumoniae and its putative role in immune-therapy |
Q37868395 | Characterization of human humoral responses to the major outer membrane protein and OMP2 ofChlamydophila pneumoniae |
Q37841512 | Defining species-specific immunodominant B cell epitopes for molecular serology of Chlamydia species |
Q90696478 | Discovery of Human-Specific Immunodominant Chlamydia trachomatis B Cell Epitopes |
Q33392388 | Evaluation of an in silico predicted specific and immunogenic antigen from the OmcB protein for the serodiagnosis of Chlamydia trachomatis infections |
Q37410691 | Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein |
Q37848670 | Molecular characterization of atypical Chlamydia and evidence of their dissemination in different European and Asian chicken flocks by specific real-time PCR. |
Q64137445 | Performance of Chlamydia trachomatis OmcB Enzyme-Linked Immunosorbent Assay in Serodiagnosis of Chlamydia trachomatis Infection in Women |
Q37856537 | Serovar-specific immune responses to peptides of variable regions of Chlamydia trachomatis major outer membrane protein in serovar D-infected women |
Q36437361 | The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding |
Search more.